SCHEMBL2183124

SCHEMBL2183124

N#Cc1ccc(-n2c3ccccc3c3cccc(-c4cnc5ccccc5c4)c32)cc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC5 O15392 1/20 0.38
PDGFRB P09619 2/20 0.38
PDGFRA P16234 2/20 0.38
PIK3CA P42336 7/20 0.37
MTOR P42345 4/20 0.37
PIK3CD O00329 3/20 0.37
PIK3C2A O00443 2/20 0.37
PIK3C2B O00750 2/20 0.37
PIK3CB P42338 2/20 0.37
PIK3CG P48736 2/20 0.37
PRKDC P78527 2/20 0.37
ATM Q13315 2/20 0.37
ATR Q13535 2/20 0.37
CHEK1 O14757 1/20 0.37
ABCB11 O95342 1/20 0.37
CSF1R P07333 1/20 0.37
MET P08581 1/20 0.37
PIK3R1 P27986 1/20 0.37
LTK P29376 1/20 0.37
CDK7 P50613 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2183119 0.89 BIRC5 (0.37) BIRC5PDGFRBPDGFRAPIK3CAMTOR
SCHEMBL951332 0.87 BIRC5 (0.37) BIRC5PDGFRBPDGFRAPIK3CAMTOR
SCHEMBL950675 0.82 HSP90AA1 (0.49) BIRC5PDGFRBPDGFRAPIK3CAMTOR
SCHEMBL420055 0.82 HSP90AA1 (0.49) BIRC5PDGFRBPDGFRAPIK3CAMTOR
SCHEMBL949880 0.82 BIRC5 (0.36) BIRC5PDGFRBPDGFRAPIK3CAMTOR
SCHEMBL422414 0.79 BIRC5 (0.41) BIRC5PDGFRBPDGFRAPIK3CAMTOR
SCHEMBL2185317 0.78 PIK3CA (0.40) BIRC5PDGFRBPDGFRAPIK3CAMTOR
SCHEMBL952602 0.78 HSP90AA1 (0.51) BIRC5PIK3CAMTORPIK3CDPIK3C2A
SCHEMBL425541 0.78 HSP90AA1 (0.51) BIRC5HSP90AA1ABCG2BRD4CREBBP
SCHEMBL2181737 0.78 CYP11B1 (0.42) PDGFRBPDGFRAPIK3CAMTORPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8309721-B2 HSP90 inhibitory carbazole derivatives, compositions containing same and use thereof SANOFI (FR) 2012-11-13 US disclosed
US-20110166169-A1 NOVEL HSP90 INHIBITORY CARBAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME AND USE THEREOF SANOFI-AVENTIS (FR) 2011-07-07 US disclosed
EP-2265598-A2 NOVEL HSP90 INHIBITORY CARBAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME, AND USE THEREOF Sanofi-Aventis (FR) 2010-12-29 EP disclosed
WO-2009122034-A2 NOVEL HSP90 INHIBITORY CARBAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME, AND USE THEREOF SANOFI-AVENTIS (FR) 2009-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166169-A1 NOVEL HSP90 INHIBITORY CARBAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME AND USE THEREOF HSP90AB2P, HSP90AB1, HSP90AA1 BIRC5 2694/4885PDGFRB 1160/4885PDGFRA 1401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.